News - Corcept Therapeutics

Filter

Current filters:

Corcept Therapeutics

Popular Filters

Cushing’s syndrome patients to receive safer drug options

22-02-2012

New upcoming treatments for Cushing’s syndrome promise to improve patient’s quality of life,…

Corcept TherapeuticsHRA PharmaKorlymMergers & AcquisitionsMifedrenNovartisPharmaceuticalRare diseasesResearchSignifor

FDA approves first Cushing’s syndrome drug, Corcept’s Korlym

20-02-2012

Shares of USA-based Corcept Therapeutics (Nasdaq: CORT) leapt 62% to $4.90 in after-hours trading on…

Corcept TherapeuticsKorlymNorth AmericaNovartisPharmaceuticalRare diseasesRegulationSignifor

Regulatory updates for Incivek, Xgeva and Corlux in North America

23-08-2011

In a batch of regulatory news released yesterday, Vertex Pharmaceuticals (Nasdaq: VRTX) said that Health…

AmgenAnti-viralsCorcept TherapeuticsCorluxIncivekNorth AmericaPharmaceuticalRare diseasesRegulationVertexXgeva

Back to top